Bascon, Baby Boy L.
HRN: 22-13-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
AMPICILLIN 250MG (VIAL)
10/21/2022
10/28/2022
IV
120mg
Q12
Potential Septic Newborn (prom)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes